1. Home
  2. FCN vs GKOS Comparison

FCN vs GKOS Comparison

Compare FCN & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCN
  • GKOS
  • Stock Information
  • Founded
  • FCN 1982
  • GKOS 1998
  • Country
  • FCN United States
  • GKOS United States
  • Employees
  • FCN N/A
  • GKOS N/A
  • Industry
  • FCN Professional Services
  • GKOS Medical/Dental Instruments
  • Sector
  • FCN Consumer Discretionary
  • GKOS Health Care
  • Exchange
  • FCN Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • FCN 7.2B
  • GKOS 7.4B
  • IPO Year
  • FCN 1996
  • GKOS 2015
  • Fundamental
  • Price
  • FCN $196.87
  • GKOS $146.41
  • Analyst Decision
  • FCN Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • FCN 1
  • GKOS 13
  • Target Price
  • FCN $275.00
  • GKOS $143.00
  • AVG Volume (30 Days)
  • FCN 188.0K
  • GKOS 496.0K
  • Earning Date
  • FCN 10-24-2024
  • GKOS 11-04-2024
  • Dividend Yield
  • FCN N/A
  • GKOS N/A
  • EPS Growth
  • FCN 28.86
  • GKOS N/A
  • EPS
  • FCN 8.71
  • GKOS N/A
  • Revenue
  • FCN $3,728,412,000.00
  • GKOS $360,347,000.00
  • Revenue This Year
  • FCN $7.62
  • GKOS $22.68
  • Revenue Next Year
  • FCN $5.01
  • GKOS $24.98
  • P/E Ratio
  • FCN $22.87
  • GKOS N/A
  • Revenue Growth
  • FCN 11.66
  • GKOS 18.70
  • 52 Week Low
  • FCN $185.93
  • GKOS $74.75
  • 52 Week High
  • FCN $243.60
  • GKOS $147.65
  • Technical
  • Relative Strength Index (RSI)
  • FCN 40.07
  • GKOS 59.18
  • Support Level
  • FCN $196.40
  • GKOS $137.60
  • Resistance Level
  • FCN $201.97
  • GKOS $147.65
  • Average True Range (ATR)
  • FCN 3.94
  • GKOS 4.74
  • MACD
  • FCN 0.06
  • GKOS 0.29
  • Stochastic Oscillator
  • FCN 10.79
  • GKOS 91.36

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance and restructuring, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Share on Social Networks: